Oppenheimer analyst Matt Biegler raised the price target on Relay Therapeutics (NASDAQ: RLAY) to $18.00 (from $14.00) while maintaining a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE